Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial on the Effect of Levilactobacillus Brevis (CNCM I-5566) Probiotic Supplement on Clinical and Salivary Oral Indicators

NCT06457724 is registered in ClinicalTrials.gov with University of L'Aquila as lead sponsor.

NCT NCT06457724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06457724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial on the Effect of Levilactobacillus Brevis (CNCM I-5566) Probiotic Supplement on Clinical and Salivary Oral Indicators
Lead sponsor
University of L'Aquila
Phase
Not applicable
Overall status
Completed
Start date
October 30, 2022
Completion date
November 30, 2023
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral disease, oral health